| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |